The effects of tolterodine extended release and alfuzosin for the treatment of double-j stent-related symptoms

Journal of Endourology

Volumn 23, Issue 11, 2009, Pages 1913-1917

  Park, Seung Chol ^a   Jung, Sung Won ^a   Lee, Jea Whan ^a   Rim, Joung Sik ^a  

^a Wonkwang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; ANTIBIOTIC AGENT; PLACEBO; TOLTERODINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOUBLE J STENT; DRUG EFFECT; DRUG RELEASE; DYSURIA; FACE EDEMA; FEMALE; HEADACHE; HEALTH STATUS; HUMAN; IMPAIRED BLADDER EMPTYING; JOB PERFORMANCE; LAPAROSCOPIC SURGERY; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; NAUSEA; NOCTURIA; PAIN; PAIN ASSESSMENT; PERCUTANEOUS NEPHROLITHOTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PYELOPLASTY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; TREATMENT DURATION; URETER STENT; URETER SURGERY; URETERAL STENT SYMPTOM QUESTIONNAIRE; URETEROSCOPY; URETEROSTOMY; URGE INCONTINENCE; URINARY TRACT INFECTION; URINARY URGENCY; UROLOGIC SURGERY; VISUAL ANALOG SCALE; XEROSTOMIA;

ADOLESCENT; ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; BENZHYDRYL COMPOUNDS; CRESOLS; DELAYED-ACTION PREPARATIONS; DEMOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; PHENYLPROPANOLAMINE; POSTOPERATIVE COMPLICATIONS; QUESTIONNAIRES; QUINAZOLINES; STENTS; YOUNG ADULT;

EID: 70449427308     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2009.0173     Document Type: Article

References (19)

1. Zimskind PD, Fetter JR, Wilkerson JL. Clinical use of longterm indwelling silicone rubber ureteral splints inserted cystoscopically. J Urol 1967;97:840-844.
2. Pollard SG, Macfarlane R. Symptoms arising from Double-J ureteral stents. J Urol 1988;139:37-38.
3. Ringel A, Richter S, Shalev M, et al. Late complications of ureteral stents. Eur Urol 2000;38:41-44.
4. Damiano R, Oliva A, Esposito C, et al. Early and late complications of double pigtail ureteral stent. Urol Int 2002;69: 136-140.
5. Aravantinos E, Gravas S, Karatzas AD, et al. Forgotten, encrusted ureteral stents: A challenging problem with an endourologic solution. J Endourol 2006;20:1045-1049.
6. Joshi HB, Newns N, Stainthorpe A, et al. Ureteral stent symptom questionnaire: Development and validation of multidimensional quality of life measure. J Urol 2003;169: 1060-1064.
7. Thomas R. Indwelling ureteral stents: Impact of material and shape on patient comfort. J Endourol 1993;7:137-140.
8. Beiko DT, Watterson JD, Knudsen BE, et al. Double-blind randomized controlled trial assessing the safety and efficacy of intravesical agents for ureteral stent symptoms after extracorporeal shockwave lithotripsy. J Endourol 2004;18:723-730.
9. Damiano R, Autorino R, De Sio M, et al. Effect of tamsulosin in preventing ureteral stent-related morbidity: A prospective study. J Endourol 2008;22:651-656.
10. Deliveliotis C, Chrisofos M, Gougousis E, et al. Is there a role for alpha1-blockers in treating double-J stent-related symptoms? Urology 2006;67:35-39.
11. Leibovici D, Cooper A, Lindner A, et al. Ureteral stents: Morbidity and impact on quality of life. Isr Med Assoc J 2005;7:491-494.
12. Joshi HB, Stainthorpe A, MacDonagh RP, et al. Indwelling ureteral stents: Evaluation of symptoms, quality of life and utility. J Urol 2003;169:1065-1069.
13. Joshi HB, Chitale SV, Nagarajan M, et al. A prospective randomized single-blind comparison of ureteral stents composed of firm and soft polymer. J Urol 2005;174:2303-2306.
14. Damiano R, Autorino R, De Sio M, et al. Does the size of ureteral stent impact urinary symptoms and quality of life? A prospective randomized study. Eur Urol 2005;48:673-678.
15. Rane A, Saleemi A, Cahill D, et al. Have stent-related symptoms anything to do with placement technique? J Endourol 2001;15:741-745.
16. Nitti VW, Dmochowski R, Appell RA, et al. Efficacy and tolerability of tolterodine extended-release in continent patients with overactive bladder and nocturia. BJU Int 2006;97: 1262-1266.
17. Agarwal A, Dhiraaj S, Singhal V, et al. Comparison of efficacy of oxybutynin and tolterodine for prevention of catheter related bladder discomfort: A prospective, randomized, placebo-controlled, double-blind study. Br J Anaesth 2006; 96:377-380.
18. Norris RD, Sur RL, Springhart WP, et al. A prospective, randomized, double-blinded placebo-controlled comparison of extended release oxybutynin versus phenazopyridine for the management of postoperative ureteral stent discomfort. Urology 2008;71:792-795.
19. Sighinolfi MC, Micali S, De Stefani S, et al. Indwelling ureteral stents and sexual health: A prospective, multivariated analysis. J Urol 2007;178:229-231.